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ABSTRACT
Objective: We reviewed the long-term results and patient
survival for laparoscopic-assisted resection of colorectal
malignancies. The place of laparoscopic colectomy for
colorectal carcinomas is controversial. The techniques and
expected surgical outcomes for patients undergoing lapa-
roscopic and laparoscopic-assisted colectomies are being
defined as these procedures become more acceptable and
reach parity with, or even surpass, results of traditional
operations. Anecdotal reports in the literature describe
port-site and incisional tumor implantation in patients
undergoing laparoscopic-assisted colectomies for colorec-
tal malignancies. This raises concerns about whether these
incisional tumor sites are more common in these patients
and whether their survival is compromised by the laparo-
scopic technique.
Methods: The authors reviewed data from 110 patients
who underwent laparoscopic-assisted colectomies for
colorectal cancer to determine the long-term results and
survival and to compare the safety and efficacy of laparo-
scopic-assisted colectomy to the safety and efficacy of
open colectomy. Between July 1991 and June 1999, 350
patients underwent laparoscopic-assisted colectomies. Of
these, 110 patients had colorectal malignancies. Survival
rates and patterns of recurrence were compared within
the various TNM stages and compared with conventional
data after open surgery. The American Joint Committee on
Cancer staging for colorectal carcinomas and the Kaplan-
Meier method were used to determine the survival curves.
Results: Laparoscopic-assisted colon resections for colo-
rectal malignancies were performed in 110 patients. Fifty-
one percent of the patients were women, and 49% percent
were men, with a mean age of 78.17 years. The mean
follow-up was 43 months. Thirteen patients were con-
verted to open operation due to various difficulties en-
countered during the procedure. Mean operative time was
128.16 minutes, and mean hospital stay was 6.91 days. Peri-
operative mortality was 2.77%. There were 4 local recur-
rences. The ten-year survival rates for the various stages were
78% for stage I, 33% for stage II, 30% for stage III, and 0% for
stage IV. No port-site implantations occurred.
Conclusion: Laparoscopic-assisted colon resection of
colorectal carcinomas is technically feasible and safe. It
allows earlier postoperative recovery and a shorter hos-
pital stay. The long-term survival is also satisfactory. The
incidence of port-site implants is no more than that with
the conventional open technique. Determination of any
benefits over the conventional open technique, however,
still await prospective randomized trials.
Key Words: Laparoscopic colon resections, Laparo-
scopic-assisted colon resections, Colorectal malignancies.
INTRODUCTION
In recent years, laparoscopic surgery has become a matter
of growing interest.1 Since its introduction in the late
1980s and the subsequent recognition of its potential ad-
vantages, minimally invasive surgery has been applied to
almost all areas of abdominal surgery.2 Laparoscopic tech-
niques have been applied to a variety of benign colorectal
conditions, including inflammatory and diverticular dis-
ease.3 These successes have prompted the development
of laparoscopic techniques for the resection of colorectal
malignancies.3
Fowler et al4 reported one of the earliest laparoscopic
sigmoid resections in 1991. Since then, numerous au-
thors have demonstrated the feasibility and safety of
laparoscopic colon surgery.2 Techniques range from
full laparoscopic procedures including intracorporeal
resection and anastomosis, to laparoscopic-assisted
procedures, where a portion of the procedure is done
extracorporeally.3 Potential short-term benefits of lapa-
roscopic colectomies include faster recovery of pulmo-
nary function, less pain from smaller incisions, reduced
ileus, lower rate of wound complications, and more
rapid mobilization of patients leading to a shorter hos-
pital stay and quicker return to normal activities–to
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SCIENTIFIC PAPERwhich has been added lower hospital costs and im-
proved cosmesis.3,5 These benefits make laparoscopic
colectomy a very attractive option. However, the surgi-
cal community has not accepted it in the same way as it
has accepted laparoscopic cholecystectomy. Accep-
tance in colorectal malignancies, especially for opera-
tions with curative intent, is controversial.6 This contro-
versy has been fueled by the well-publicized anecdotal
reports of port-site tumor implantations.7 Other contro-
versies include long-term survival and adequacy of re-
section.1 Further, it has been suggested that cancer cells
can be spread at the time of the laparoscopic resection,
through the misuse of instruments, detrimental effects
of CO2 pneumoperitoneum, or movement of cell laden
fluid.7 However, emerging data show benefits for pa-
tients treated laparoscopically for colon and rectal ad-
enocarcinomas.7
Several recent reports exist describing wound tumor implan-
tations after open colectomies, but only 2 large series report
an incidence of 1% and 1.5%.8,9 Very limited reports exist on
long-term survival for these patients. The purpose of our
study was to define the survival curves in a cohort of con-
secutive patients who underwent laparoscopic resection of
colorectal malignancies and to review the literature.
Table 1.
Complications
Complication Number Comments Due to LAC*
Deaths† 3 No
Bleeding 1 Required reoperation Yes
Bladder
injury
1 Repaired intraoperatively Yes
Small
bowel
injury
3 Repaired intraoperatively Yes
Pneumonia 1 No
Wound
infection
1 No
Hypotension 1 No
Small
bowel
obstruction
1 Unknown
Intraabdominal
abscesses
2 Required reoperation No
Urinary
tract
infection
4 No
Ileus 8 Unknown
*LAC  laparoscopic assisted colectomy.
†Two patients succumbed to their metastatic disease; 1 patient died of complications of pneumonia.
Figure 1. Kaplan-Meier survival curves per tumor stage.
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The charts of 350 consecutive patients who underwent
laparoscopic-assisted colon resections for both benign
and malignant disease of the colon between July 1991 and
June 1999 were reviewed retrospectively. These charts
also included attempted laparoscopic procedures that
were converted to open operations. Inpatient and outpa-
tient records were reviewed for patient demographics,
(including age, sex, and associated co-morbidities) as well
as the details of the operation, (including procedure per-
formed, indication and duration of operation, intraopera-
tive and postoperative complications, conversion to open
procedure, time taken to resumption of diet and length of
hospital stay). The follow-up was also reviewed including
complications and recurrences. All these data were then
compared with our open colectomy data obtained from
our database for colorectal carcinomas accrued before we
started performing laparoscopic-assisted colectomies.
All patients underwent laparoscopic-assisted resections,
with the mobilization performed laparoscopically, and the
resection and anastomosis accomplished extracorpore-
ally. No special precaution was taken to remove the spec-
imen. Total operative time was defined as the time from
initial incision to completion of closure. Operative records
were reviewed for total blood loss and the need for blood
transfusion. Diet was initiated on return of bowel func-
tion, starting from fluids, and advancing as tolerated. The
patients were discharged home when they were passing
flatus or stool, or both, tolerating a soft or regular diet, and
receiving adequate relief from oral pain medications. Dis-
charge criteria however were not strictly enforced, and
patients were sometimes allowed to stay longer, even
after achieving these goals.
All patients were staged postoperatively, using the Amer-
ican Joint Committee of Cancer staging system (TNM clas-
sification) as stage I, II, III, and IV. The TNM classification
Figure 2. Kaplan-Meier survival curves per node status.
Figure 3. Kaplan-Meier survival curves per metastasis stage.
Figure 4. Kaplan-Meier survival curves per AJCC stage. Stage 1
range, 72–74%; stage 2 range 54–63%; stage 3 range, 39–46%;
stage 4 range, 6–7%. Adapted from Beart RW, Steele GD Jr,
Menck HR, Chmiel JS, Ocwieja KE, Winchester DP. Management
and survival of patients with adenocarcinoma of the colon and
rectum: a national survey of the Commission on Cancer. J Am
Coll Surg. 1995;181:225–236.
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to correspond directly to the Dukes classification, which is
often used to estimate the prognosis of the disease (8/15).
The survival rates for all stages were determined using the
Kaplan-Meier curve. Estimates for overall 2-year, 5-year,
and 10-year survival were calculated from the values used
to determine the Kaplan-Meier curves.
RESULTS
Starting from July 1991, 350 laparoscopic-assisted colon
resections were performed. Of these, 240 were for benign
disease, while 110 were for malignant disease. Of the 110
patients with malignancy, 50.9% were female. The mean
age was 78.17(standard deviation of 11.3 years; range, 54
to 91 years). There were 4 abdominoperineal resections, 6
low anterior resections, 5 transverse colectomies, 8 left
hemicolectomies, 25 sigmoid resections, and 62 right
hemicolectomies.
The margins and lymph nodes obtained were also re-
viewed in this study. The mean proximal margin was 8.57
cm (SD, 5.52 cm; range, 1 cm to 31 cm), while the distal
margin was 8.23 cm (SD, 5.5 cm; range, 1cm to 33cm). The
mean number of lymph nodes obtained were 10.75 (SD,
6.8; range, 0 to 37), and the number of positive lymph
nodes was mean 1.46 (SD, 2.93; range, 0 to 21).
The conversion rate was 11.81% (13 patients). Conversion
was defined as inability to mobilize the colon laparoscopi-
cally. The reason for conversion included adhesions (6
patients), technical difficulty (5 patients), and unexpected
findings (2 patients). The mean operative time was 128.16
minutes (SD, 69.9; range, 35 to 495). In our open colec-
tomy database, the mean operative time was 155 minutes.
The mean time for resumption of a clear fluid diet was
2.28 days (SD, 1.37; range, 1 to 8 days); while a regular
diet was tolerated in 4.21 days (SD, 2.34; range, 2 to 15
days). Mean length of hospital stay was 6.91 days (SD,
4.24; range, 2 to 25 days). In our open colectomy data-
base, the mean time to starting a clear diet was 3.9 days,
and mean hospital stay was 12.5 days.
The perioperative mortality was 2.77% (3 patients). Two
patients succumbed to their metastatic disease, while 1
patient died of complications of pneumonia. Table 1 lists
the 23 complications that occurred. Of these, 7 necessi-
tated surgical intervention. One had intraabdominal
bleeding, requiring return to the operating room, while 1
bladder injury and 3 small bowel injuries were identified
and repaired laparoscopically at the same time as the
primary surgery. Two patients had intraabdominal ab-
scesses and required a re-exploration.
There were 4 local recurrences, 3 after right colectomies
and 1 after a left colectomy. No port-site recurrences were
observed.
Follow-up data were available for 104 patients. Twenty-
six patients had Stage I disease, 34 had Stage II, 35 had
Stage III, and 9 had Stage IV disease. The mean follow-up
for all patients was 43 months (SD 36.5; range, 1 to 104).
As determined by the Kaplan-Meier curves, the 2-year,
5-year, and 8-year survival for these patients was stage I
(100%, 94%, 78%), stage II (94%, 66%, 33%), stage III (82%,
55%, 30%), and stage IV (20%, 0%, 0%). For the TNM
staging, the 5- and 8-year survival for the lesion was T1
(100% and 82%), T2 (84% and 70%), T3 (54% and 26%);
there were no 5- or 8-year survivors for T4 lesions. For
nodal disease, the 5- and 8-year survival was N0 (70% and
46%), N1 (44% and 30%) with no survivors for N2. Simi-
larly, the 5- and 8-year survival for patients with no met-
astatic disease was 70% and 42%, respectively. There were
no survivors of metastatic disease.
DISCUSSION
Laparoscopic cholecystectomy has been widely accepted
by surgeons because of its minimally invasive nature and
physiologic, perioperative benefits. However, the appli-
cation of laparoscopic surgery for colorectal malignancies
is still controversial because for any malignancy the long-
term benefits are more important than the benefits ob-
tained in the immediate postoperative period. If we can
demonstrate that the long-term survival achieved by lapa-
roscopic procedures is no less than that achieved by the
conventional open technique, that result in itself should
be sufficient to establish the advantage of laparoscopic
and laparoscopic-assisted resections of colorectal malig-
nancies.
Like other laparoscopic operations, laparoscopic colecto-
mies offer many short-term benefits to patients. These
include less pain, reduced ileus with earlier resumption of
diet, shorter hospital stay, and more rapid return to a
functional status. In our series of 110 patients, the patients
were started on a diet earlier in the laparoscopic group,
with an earlier discharge from the hospital.
Our overall conversion rate of 11.81% was comparable to
conversion rates reported in other series. Our operative
time was less than that for open colectomies. Of 3 peri-
operative mortalities, none was directly related to the
laparoscopic procedure itself. The complications, of small
JSLS (2005)9:184–188 187bowel injury in 3 patients and bladder injury in 1 patient,
though directly related to the laparoscopic procedure, was
recognized immediately and repaired laparoscopically.
On follow-up, the 5-year survival for each stage is no
different in the laparoscopic data as compared to the data
obtained from open series.10 They compare stage-to-
stage, Stage I (94% vs 72% to 74%), Stage II (66% vs 54%
to 63%), Stage III (55% vs 39% to 46%), and Stage IV (0%
vs 6% to 7%).
Port-site tumor implantations have been a matter of much
concern with laparoscopic and laparoscopic-assisted co-
lectomies. However, this may just represent an underes-
timation of wound implants in open techniques or an
overestimation in laparoscopic surgery, wherein port-site
“recurrences” just represent a part of widespread metas-
tases. In our series, we had no trocar-site or incisional
implants. This correlates well with other series that report
port-site implants of approximately 1% or less, which is
about the same as the wound tumor implantation rate of
0.6% to 1.5% reported for open procedures.
Despite a few contradictory reports, most clinical and
experimental studies support the view that laparoscopic
surgery is associated with better preservation of immune
function.11 The minimal access technique is believed to
produce an attenuated metabolic stress response and rep-
resents a milder challenge to the immune response.11,12
This beneficial trait is purportedly related to the smaller
incision. Theoretically, in the long-term, the better im-
mune status in the early postoperative period will translate
into longer survival for patients with cancer.6
CONCLUSION
Laparoscopic-assisted colectomy for colorectal malignan-
cies is a technically feasible procedure that can be per-
formed effectively and safely, with a superior quality of
life outcome. The learning curve is still an ongoing pro-
cess and depends on the level of competence of the
surgeon and operating room staff. In our review of 110
operations performed at our institution during the study
period, we have demonstrated an acceptable outcome
concerning conversion rates, mortality, morbidity, and
hospital stay. Also, the survival curves for patients with
colorectal malignancies undergoing laparoscopic-assisted
resections do not differ negatively from the results of
conventional open surgery. Short-term results are favor-
able to those of laparoscopic-assisted colectomies; how-
ever, final answers await longer follow-up and results of
prospective randomized trials.
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